Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In Ethiopia, CQ efficacy remains above 95% although sporadic reports of CQ failure suggest emerging resistance [8, 13–20].”
In the citing paper
“Studies conducted since 2006 by EPHI and others have shown a high efficacy of AL against P. falciparum, confirming the drug remains well-tolerated and effective for the intended use in Ethiopia [4, 5, 8–10, 15, 19, 34, 35].”
In the citing paper
“Chloroquine resistance against P. vivax has been reported in Ethiopia and in Southeast Asia [15, 34, 42].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 36
- Guerra CA, Snow RW, Hay SI: Mapping the global extent of malaria in 2005. Trends Parasitol. 2006, 22: 353-358. 10.1016/j.pt.2006.06.006. · DOI · Paper page
- Mendis K, Sina BJ, Marchesini P, Richard C: The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001, 64: 97-106. · DOI · Paper page
- Federal Ministry of Health: National Five Years Strategic Plan for Malaria Control in Ethiopia: 2001–2005. 2005, Malaria and Other Vector-borne Diseases Prevention and Control Team, Diseases Prevention and Control Department, Ministry of Health, Addis Ababa
- Rieckmann KH, Davis DR, Hutton DC: Plasmodium vivax resistant to chloroquine?. Lancet. 1989, 2: 1183-1184. 10.1016/S0140-6736(89)91792-3. · DOI · Paper page
- Baird JK, Basri H, Purnomo , Bangs MJ, Subianto B, Patchen LC, Hoffman SL: Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg. 1991, 44: 547-552. · DOI · Paper page
- Myat Phone K, Myint O, Myint L, Thaw Z, Kyin HA, Nwe NY: Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Trans R Soc Trop Med Hyg. 1993, 87: 687-10.1016/0035-9203(93)90294-Z. · DOI
- Marlar T, Myat PK, Aye YS, Khaing KG, Ma S, Mind O: Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Trans R Soc Trop Med Hyg. 1995, 89: 307-308. 10.1016/0035-9203(95)90556-1. · DOI
- Dua VK, Kar PK, Sharma VP: Chloroquine resistant Plasmodium vivax malaria in India. Trop Med Int Health. 1996, 1: 816-819. · DOI
- Fryauff DJ, Tuti S, Mardi A, Masbar S, Patipelohi R, Leksana B, Kain KC, Bangs MJ, Richie TL, Baird JK: Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. Am J Trop Med Hyg. 1998, 59: 513-518. · doi:10.4269/ajtmh.1998.59.513
- Phillips EJ, Keystone JS, Kain KC: Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin Infect Dis. 1996, 23: 1171-1173. · DOI
- Alecrim MG, Alecrim W, Macedo V: Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region. Rev Soc Bras Med Trop. 1999, 32: 67-68. · DOI
- Villalobos-Salcedo JM, Tada MS, Kimura E, Menezes MJ, Pereira da Silva LH: In-vivo sensitivity of Plasmodium vivax isolates from Rond nia (western Amazon region, Brazil) to regimens including chloroquine and primaquine. Ann Trop Med Parasitol. 2000, 94: 749-758. 10.1080/00034980020027960. · doi:10.1080/00034980020027960
- de Santana Filho FS, Arcanjo AR, Chehuan YM, Costa MR, Martinez-Espinosa FE, Vieira JL, Barbosa MG, Alecrim WD, Alecrim MG: Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerg Infect Dis. 2007, 13: 1125-1126. · DOI · Paper page
- Soto J, Toledo J, Gutierrez P, Luzz M, Llinas N, Cedeno N, Dunne M, Berman J: Plasmodium vivax clinically resistant to chloroquine in Colombia. Am J Trop Med Hyg. 2001, 65: 90-93. · doi:10.4269/ajtmh.2001.65.90
- Phan GT, de Vries PJ, Tran BQ, Le HQ, Nguyen NV, Nguyen TV, Heisterkamp SH, Kager PA: Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam. Trop Med Int Health. 2002, 7: 858-864. 10.1046/j.1365-3156.2002.00948.x. · DOI
- Ruebush TK, Zegarra J, Cairo J, Andersen EM, Green M, Pillai DR, Marquino W, Huilca M, Arevalo E, Garcia C, Solary L, Kain KC: Chloroquine resistant Plasmodium vivax malaria in Peru. Am J Trop Med Hyg. 2003, 69: 548-552. · doi:10.4269/ajtmh.2003.69.548
- Kurcer MA, Simsek Z, Zeyrek FY, Atay S, Celik H, Kat I, Topluoglu A: Efficacy of chloroquine in the treatment of Plasmodium vivax malaria in Turkey. Ann Trop Med Parasitol. 2004, 98: 447-451. 10.1179/000349804225021343. · doi:10.1179/000349804225021343
- Sumawinata IW, Bernadeta BL, Awalludin S, Purnomo B, Subianto S, Fryauff DJ, Baird JK: Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. Am J Trop Med Hyg. 2003, 68: 416-420. · DOI
- Jima D, Tesfaye G, Medhin A, Kebede A, Aragaw D, Babaniyi O: Efficacy of sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Ethiopia. East Afr Med J. 2005, 82 (8): 391-395.
- Jima D, Tesfaye G, Medhin A, Kebede A, Aragaw D, Babaniyi O: Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia. East Afr Med J. 2005, 82 (8): 387-390.
- Tulu NA, Webbeg RH, Schellenberg JA, Bradley DJ: Failure of chloroquine treatment for malaria in the highlands of Ethiopia. Trans R Soc Trop Med Hyg. 1996, 90: 556-557. 10.1016/S0035-9203(96)90322-3. · DOI · Paper page
- Central Statistics Agency: Estimate of population size by sex, area and density by region, zone and woreda, July 2007 based on census done in 1994. 2006, Addis Ababa
- National Meteorology Agency: Monthly data of rainfall and temperature from 1996–2006 of Debre Zeit. 2008, Addis Ababa
- WHO: Monitoring anti-malarial drug resistance. 2002, Report of a WHO Consultation Geneva, Switzerland
- WHO: Management of severe malaria. 2002, Practical Hand Book, 2
- FMOH: Malaria diagnosis and treatment guidelines for health workers in Ethiopia. 2004, Addis Ababa, 2
- Baird JK, Leksana B, Masbar S, Suradi , Sutanihardja MA, Fryauff DJ, Subianto B: Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am J Trop Med Hyg. 1997, 56: 621-626. · DOI · Paper page
- Cheesbourgh M: District Laboratory practice in Tropical countries. 2000, Gapsons papers Ltd, NOIDA, II: 2
- British Pharmacopoeia commission: British pharmacopoeia. 2004, II:
- Bell DJ, Nyirongo SK, Molyneux ME, Winstanley PA, Ward SA: Practical HPLC methods for the quantitative determination of common antimalarials in Africa. J Chromatogr B. 2007, 847: 231-236. 10.1016/j.jchromb.2006.10.020. · doi:10.1016/j.jchromb.2006.10.020
- Bruce CM, Galinsky RM, Barnwell JW, Snounou G, Day KP: Polymorphism at merozoite surface protein-3a locus of Plasmodium vivax: global and local diversity. Am J Trop Med Hyg. 1999, 61: 518-525. · DOI
- Baird JK: Minireview: chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother. 2004, 48: 4075-4083. 10.1128/AAC.48.11.4075-4083.2004. · DOI · Paper page
- Imwong M, Pukrittayakamee S, Grüner AC, Rénia L, Letourneur F, Looareesuwan S, White NJ, Snounou G: Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Malaria J. 2005, 4: 20-10.1186/1475-2875-4-20. · DOI · Paper page
- Craig AA, Kain KC: Molecular analysis of strains of Plasmodium vivax from paired primary and relapse infections. J Infect Dis. 1996, 174: 373-379. · doi:10.1093/infdis/174.2.373
- Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, Guthmann JP, Nosten F, Carlton J, Looareesuwan S, Nair S, Sudimack D, Day NP, Anderson TJ, White NJ: Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis. 2007, 195: 927-933. 10.1086/512241. · DOI · Paper page
- Chen N, Auliff A, Rieckmann K, Gatton M, Cheng Q: Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J Infect Dis. 2007, 195: 934-941. 10.1086/512242. · DOI · Paper page
Cited by
The International Limits and Population at Risk of Plasmodium vivax Transmission in 2009
Guerra, C. A., Howes, R. E., Patil, A. P., Gething, P. W., Van Boeckel, T. P., Temperley, W. H., Kabaria, C. W., Tatem, A. J., Manh, B. H., Elyazar, I. R. F., et al. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000774 · Cited by 460
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance
Price, R. N., Douglas, N. M., & Anstey, N. M. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32832f14c1 · Cited by 343
Malaria epidemiology and interventions in Ethiopia from 2001 to 2016
Taffese, H. S., Hemming-Schroeder, E., Koepfli, C., Tesfaye, G., Lee, M.-C., Kazura, J., Yan, G.-Y., & Zhou, G.-F. (2018) · Infectious Diseases of Poverty · doi:10.1186/s40249-018-0487-3 · Cited by 268
Self-citationClimatic variables and malaria transmission dynamics in Jimma town, South West Ethiopia
Alemu, A., Abebe, G., Tsegaye, W., & Golassa, L. (2011) · Parasites & Vectors · doi:10.1186/1756-3305-4-30 · Cited by 215
Assefa, A., Mohammed, H., Anand, A., Abera, A., Sime, H., Minta, A. A., Tadesse, M., Tadesse, Y., Girma, S., Bekele, W., et al. (2022) · Malaria Journal · doi:10.1186/s12936-022-04350-z · Cited by 20
Self-citation
Metadata
- Authors
- Teka, H., Petros, B., Yamuah, L., Tesfaye, G., Elhassan, I., Muchohi, S., Kokwaro, G., Aseffa, A., & Engers, H.
- Venue
- Malaria Journal
- Published
- 2008-10-29
- Volume
- 7
- Issue
- 1
- ISSN
- 1475-2875
- Cited by
- 86
- References
- 0
- Language
- en
- Licence
- creativecommons.org/licenses/by/2.0 (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia. https://app.cochat.ai/papers/10.1186/1475-2875-7-220
- The paper
- Teka, H., Petros, B., Yamuah, L., Tesfaye, G., Elhassan, I., Muchohi, S., Kokwaro, G., Aseffa, A., & Engers, H. (2008). Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia. Malaria Journal. https://doi.org/10.1186/1475-2875-7-220
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.